The invention relates to a
medicine for treating
rheumatoid arthritis, which is characterized by being composed of the following medicinal materials:
Astragalus membranaceus, root of fangji, herba lycopi,
bark of ash, Uniflower Swisscentaury Root, ramulus mori,
lycopodium clavatum, Giantleaf
Ardisia Rhizome, Potaliaceae, ground beeltle,
lumbricus, hematoxylon, zedoary,
radix aconiti preparata, licorice root,
cassia twig,
radix aconiti lateralis preparata, root of common peony, ephedra, Radix Saposhnikoviae, rhizoma atractylodis,
Angelica sinensis,
Asarum sieboldii,
Pinellia ternate, rhizoma arisaematis,
coix seed, spina gleditsiae, radix clematidis,
human placenta and
achyranthes root. The
medicine has the effects of dispelling wind, eliminating dampness and stopping spasm, activating yang, dispelling cold, eliminating stasis to subdue swelling, eliminating dampness and
phlegm, warming the kidneys and tonifying
spleen, has the major
treatment effect on
rheumatoid arthritis, particularly on progressive
rheumatoid arthritis which is clinically difficult to cure. The
medicine has steady and reliable
curative effect, recurrence rate is low, clinical medication research on about one thousand patients shows that the
cure rate is more than 90% in treatment of pain caused by rheumatoid
arthritis, seasonal aggravation symptom,
joint deformity and the like; and by clinical contrast test, the total effective rate is more than 97%,
curative effect is obviously better than that of a control group.